Head And Neck Cancer
Showing 8 of 12 results
Cholesterol Drug Repurposed as Investigational Therapy for HPV+ Cancers at University Hospitals Seidman Cancer Center in Nation’s First-Ever Clinical Trials
Published pre-clinical results show fenofibrate restores function of key tumor suppressor gene in these cancers | Innovations in Cancer February 2025
Navigating the Complex Mechanisms of HPV+ Head and Neck Cancers
Quintin Pan, PhD, explores the surge of HPV+ related head and neck cancers sparking the need for innovative treatment solutions.
University Hospitals Seidman Cancer Center Launches Biotech Collaboration to Discover Cellular Immunotherapies for Head and Neck Cancer
Innovations in Ear, Nose & Throat | Winter 2023
University Hospitals Hosts Oral Cancer Screening at Housing Shelter
UH Seidman Cancer Center Update | December 2020
Understanding Racial Disparities in Head and Neck Cancer
Study from UH Seidman Cancer Center suggests biological differences in tumors between African-Americans and European-Americans driving differences in outcomes - Innovations in Cancer | Fall 2020
Wesley Family donates $10 million to University Hospitals Seidman Cancer Center
Gift establishes groundbreaking immunotherapy center - UH News Release
The Vision of Jorge A. Garcia, MD
A conversion with the new division chief of Solid Tumor Oncology | August 2020
HPV-Associated Head and Neck Cancer Treatment
UH researchers identify outlier HPV strain, study cancer stem cells - Innovations in Ear, Nose & Throat | Winter 2020